HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
KDELR2
KDEL endoplasmic reticulum protein retention receptor 2
Chromosome 7 Β· 7p22.1
NCBI Gene: 11014Ensembl: ENSG00000136240.11HGNC: HGNC:6305UniProt: P33947
56PubMed Papers
21Diseases
0Drugs
4Pathogenic Variants
FUNCTIONAL ROLE
ReceptorTransporter
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
COPI-coated vesicle membraneKDEL sequence bindingGolgi membraneendoplasmic reticulum membraneosteogenesis imperfecta, type 21Increased susceptibility to fracturesJoint hypermobilityscoliosis
✦AI Summary

KDELR2 encodes KDEL endoplasmic reticulum protein retention receptor 2, which serves as a membrane receptor that binds the KDEL sequence motif in ER-resident proteins and maintains their localization through vesicle-mediated recycling from the Golgi back to the ER 1. The receptor functions in pH-dependent manner and participates in COPI retrograde transport 1. KDELR2 plays a critical role in collagen metabolism by interacting with HSP47, a molecular chaperone essential for collagen type I folding 1. Bi-allelic pathogenic variants in KDELR2 cause osteogenesis imperfecta type XXI by disrupting the KDELR2-HSP47 interaction, leading to HSP47 remaining bound to collagen extracellularly and disrupting fiber formation 12. Beyond its classical ER function, KDELR2 exhibits oncogenic properties in multiple cancers. It promotes tumor progression through cell cycle regulation, particularly by protecting centrosomal protein POC5 from degradation and regulating CCND1 expression 34. KDELR2 enhances cancer cell proliferation, invasion, and metastasis by promoting Golgi-mediated secretion, including matrix metalloprotease secretion 5. In respiratory disease, KDELR2 contributes to COPD pathology by regulating MUC5AC mucin hypersecretion through IRE1Ξ±/XBP-1s signaling pathways 6. High KDELR2 expression correlates with poor prognosis across multiple cancer types 47.

Sources cited
1
KDELR2 binds KDEL sequence motif, participates in ER-Golgi recycling, interacts with HSP47, and causes osteogenesis imperfecta when mutated
PMID: 33053334
2
KDELR2 mutations cause osteogenesis imperfecta type XXI
PMID: 39127989
3
KDELR2 promotes breast cancer proliferation via HDAC3-mediated cell cycle progression and POC5 protection
PMID: 34146461
4
KDELR2 is upregulated in glioma, promotes tumor progression by regulating CCND1, and correlates with poor prognosis
PMID: 32534703
5
KDELR2 drives lung cancer invasion and metastasis by enhancing Golgi-mediated secretion including MMPs
PMID: 32753652
6
KDELR2 promotes bladder cancer cell proliferation, invasion, and migration; correlates with poor survival
PMID: 39691708
7
KDELR2 regulates MUC5AC mucin hypersecretion in COPD through IRE1Ξ±/XBP-1s signaling
PMID: 39365189
Disease Associationsβ“˜21
osteogenesis imperfecta, type 21Open Targets
0.76Strong
Increased susceptibility to fracturesOpen Targets
0.46Moderate
Joint hypermobilityOpen Targets
0.46Moderate
scoliosisOpen Targets
0.46Moderate
atopic eczemaOpen Targets
0.42Moderate
osteoarthritisOpen Targets
0.41Moderate
osteogenesis imperfectaOpen Targets
0.37Weak
inflammatory bowel diseaseOpen Targets
0.28Weak
Crohn's diseaseOpen Targets
0.28Weak
gliomaOpen Targets
0.08Suggestive
neoplasmOpen Targets
0.08Suggestive
cancerOpen Targets
0.08Suggestive
bladder transitional cell carcinomaOpen Targets
0.08Suggestive
breast cancerOpen Targets
0.08Suggestive
Gorham-Stout diseaseOpen Targets
0.07Suggestive
chronic obstructive pulmonary diseaseOpen Targets
0.07Suggestive
cleft palate-lateral synechia syndromeOpen Targets
0.06Suggestive
van der Woude syndromeOpen Targets
0.05Suggestive
Ankyloblepharon filiforme adnatum - cleft palateOpen Targets
0.05Suggestive
ankyloblepharon filiforme adnatum-cleft palate syndromeOpen Targets
0.05Suggestive
Osteogenesis imperfecta 21UniProt
Pathogenic Variants4
NM_006854.4(KDELR2):c.13C>T (p.Arg5Trp)Pathogenic
Osteogenesis imperfecta, type 21
β˜†β˜†β˜†β˜†2021β†’ Residue 5
NM_006854.4(KDELR2):c.485A>G (p.Tyr162Cys)Pathogenic
Osteogenesis imperfecta, type 21
β˜†β˜†β˜†β˜†2021β†’ Residue 162
NM_006854.4(KDELR2):c.448dup (p.His150fs)Pathogenic
Osteogenesis imperfecta, type 21
β˜†β˜†β˜†β˜†2020β†’ Residue 150
NM_006854.4(KDELR2):c.360G>A (p.Trp120Ter)Pathogenic
Osteogenesis imperfecta, type 21
β˜†β˜†β˜†β˜†2020β†’ Residue 120
View on ClinVar β†—
Related Genes
RER1Shared pathway100%COPZ1Protein interaction100%KDELR3Protein interaction95%KDELR1Protein interaction95%GOLPH3Protein interaction92%ARCN1Protein interaction92%
Tissue Expression6 tissues
Liver
100%
Lung
41%
Heart
35%
Ovary
29%
Brain
27%
Bone Marrow
14%
Gene Interaction Network
Click a node to explore
KDELR2RER1COPZ1KDELR3KDELR1GOLPH3ARCN1
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt P33947
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.32LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.76 [0.45–1.32]
RankingsWhere KDELR2 stands among ~20K protein-coding genes
  • #8,088of 20,598
    Most Researched56
  • #3,783of 5,498
    Most Pathogenic Variants4
  • #13,832of 17,882
    Most Constrained (LOEUF)1.32
Genes detectedKDELR2
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Update on the Genetics of Osteogenesis Imperfecta.
PMID: 39127989
Calcif Tissue Int Β· 2024
1.00
2
KDELR2 promotes breast cancer proliferation via HDAC3-mediated cell cycle progression.
PMID: 34146461
Cancer Commun (Lond) Β· 2021
0.90
3
Machine learning-based radiomics for predicting outcomes in cervical cancer patients undergoing concurrent chemoradiotherapy.
PMID: 38801795
Comput Biol Med Β· 2024
0.80
4
IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion.
PMID: 32753652
Oncogene Β· 2020
0.70
5
A new perspective on macrophage-targeted drug research: the potential of
PMID: 39691708
Front Immunol Β· 2024
0.60